Completed PHASE2 INTERVENTIONAL 2-arm NCT01303094

Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma (T-DIS)

Phase II Randomized Trial to Evaluate Two Strategies: Continuing Versus Intermittent (Drug-holiday) Trabectedin-regimen in Patients With Advanced Soft Tissue Sarcoma Experiencing Response or Stable Disease After the Sixth Cycle

Sponsor: Centre Oscar Lambret

Conditions Soft Tissue Sarcoma Uterine Sarcoma

Interventions Drug: holiday Trabectedin

Updated 9 times since 2017 Last updated: May 29, 2019 Started: Feb 28, 2011 Primary completion: May 16, 2018 Completion: Aug 9, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01303094, this PHASE2 trial focuses on Soft Tissue Sarcoma and Uterine Sarcoma and remains completed. Sponsored by Centre Oscar Lambret, it has been updated 9 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2019 — Jan 2021 [monthly]

Completed PHASE2

Status: Unknown Status → Completed

▶ Show 4 earlier versions

Feb 2019 — Jun 2019 [monthly]

Unknown Status PHASE2
Aug 2018 — Feb 2019 [monthly]

Unknown Status PHASE2

Status: Active Not Recruiting → Unknown Status
Jun 2018 — Aug 2018 [monthly]

Active Not Recruiting PHASE2
Jan 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE2

First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Oscar Lambret
French Sarcoma Group
Study Group of Bone Tumors

Data source: Centre Oscar Lambret

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Besançon, France , Bordeaux, France , Caen, France , Clermont-Ferrand, France , Dijon, France , Lille, France , Lyon, France , Marseille, France , Nice, France , Paris, France and 4 more locations